ClinicalTrials.gov
public full text
Public Domain
An Open-Label Study of Vascazen in Cardiac Rehab Patients With Deficient Blood Omega-3 Fatty Acid Levels
The investigators aim to test the hypothesis that dietary supplementation with VASCAZEN will correct omega-3 deficiency in cardiac rehab patients and improve biochemical risk factors.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Survey on Cardiovascular Events in Patients With Metabolic Disease on Chronic Carnitine Supplementation#872887
- Arterial Destiffening Effects of SGLT2 Inhibition in Veterans With Obesity#833285
- South Korean Pitavastatin Heart Failure Study#899438
- Relación entre la carga física ocupacional y la salud metabólica: asociación entre el comportamiento sedentario extralaboral con el riesgo cardiovascular en trabajadores de la construcción#228397
- Metabolic Modulation as Treatment in Acute Heart Failure#1008399
Record · ID 1163322
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive